Objective: To investigate the application and therapeutic effect of frontal muscle fascia compound flap suspension for congenital blepharoptosis in children.
Methods: From July 2010 to March 2012, 21 children (23 eyes) with congenital blepharoptosis were treated with frontal muscle fascia compound flap suspension. The therapeutic effect was observed and followed up.
Results: 17 patients were followed up for 3-6 months with relapse in one case. The ptosis was corrected in the other 1 cases.
Conclusion: The frontal muscle fascia compound flap suspension is effective and practical with minimal morbidity and lower complication for the correction of congenital blepharoptosis.